Beth A. Schrope

About this provider

Beth A. Schrope is listed in general surgery in New York, NY. Reported medical education includes Temple University School Of Medicine (1996).

Education & training

• TEMPLE UNIVERSITY SCHOOL OF MEDICINE · 1996 Source ↗
• Temple University School of Medicine Source ↗
• NewYork-Presbyterian Hospital/Columbia University Medical Center Source ↗
• NewYork-Presbyterian Hospital/Columbia University Medical Center Source ↗
• Temple University School of Medicine Source ↗
• NewYork-Presbyterian Hospital/Columbia University Medical Center Source ↗
• NewYork-Presbyterian Hospital/Columbia University Medical Center Source ↗
• Temple University School of Medicine Source ↗
• NewYork-Presbyterian Hospital/Columbia University Medical Center Source ↗
• NewYork-Presbyterian Hospital/Columbia University Medical Center Source ↗

Source-reported information; confirm current details directly.

Reported credentials

• Surgery Source ↗
• Surgery Source ↗
• Surgery Source ↗
• Surgery Source ↗
• Surgery Source ↗

Source-reported information; confirm current details directly.

Reported affiliations

• TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK Source ↗
• NewYork-Presbyterian / Columbia University Irving Medical Center Source ↗
• NewYork-Presbyterian Allen Hospital Source ↗
• NewYork-Presbyterian Westchester Source ↗
• NewYork-Presbyterian / Columbia University Irving Medical Center Source ↗
• NewYork-Presbyterian Allen Hospital Source ↗
• NewYork-Presbyterian Westchester Source ↗
• NewYork-Presbyterian / Columbia University Irving Medical Center Source ↗
• NewYork-Presbyterian Allen Hospital Source ↗
• NewYork-Presbyterian Westchester Source ↗

Source-reported information; confirm current details directly.

Selected publications

• Motixafortide, cemiplimab, gemcitabine and nab-paclitaxel in metastatic pancreatic cancer: a single-arm phase 2 study with single-cell correlatives. · 2026 Source ↗
• EUS-guided drainage of symptomatic postoperative fluid collections: a retrospective cohort study evaluating timing of intervention and clinical outcomes. · 2026 Source ↗
• A phase 0, window of opportunity study of parasympathetic stimulation with bethanechol in localized pancreatic adenocarcinoma prior to surgery. · 2025 Source ↗
• Trends in the Care of Locally Advanced Pancreatic Cancer in the Modern Era of Chemotherapy. · 2024 Source ↗
• Chemotherapy and Immune Checkpoint Blockade for Gastric and Gastroesophageal Junction Adenocarcinoma. · 2023 Source ↗
• Evolving Technique for Puestow-Type Procedure for Chronic Pancreatitis: The Combined Roux-en-Y Proximal End-to-Side and Distal Longitudinal Pancreatojejunostomy. · 2024 Source ↗
• Transfusion of salvaged red blood cells during pancreatic ductal adenocarcinoma operations. · 2023 Source ↗
• Associations Between Patient Characteristics and Whipple Procedure Outcomes Before and After Implementation of an Enhanced Recovery After Surgery Protocol. · 2023 Source ↗
• Long-term follow-up experience with adjuvant therapy after irreversible electroporation of locally advanced pancreatic cancer. · 2022 Source ↗
• Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma. · 2022 Source ↗
• Socioeconomic Predictors of Access to Care for Patients with Operatively Managed Pancreatic Cancer in New York State. · 2022 Source ↗
• Prevalence and Risk Factors for Pancreatic Insufficiency After Partial Pancreatectomy. · 2022 Source ↗
• Perioperative and persistent opioid utilization following pancreatectomy in the United States. · 2022 Source ↗
• Review of minimally invasive pancreas surgery and opinion on its incorporation into low volume and resource poor centres. · 2021 Source ↗
• Arguments against the Requirement of a Biological License Application for Human Pancreatic Islets: The Position Statement of the Islets for US Collaborative Presented during the FDA Advisory Committee Meeting. · 2021 Source ↗
• Proximal Gastrectomy Is a Viable Alternative to Total Gastrectomy in Early Stage Proximal Gastric Cancer. · 2021 Source ↗
• Long-term quality of life and global health following pancreatic surgery for benign and malignant pathologies. · 2021 Source ↗
• Anticoagulation practices in total pancreatectomy with autologous islet cell transplant patients: an international survey of clinical programs. · 2021 Source ↗
• What Is New with Total Pancreatectomy and Autologous Islet Cell Transplantation? Review of Current Progress in the Field. · 2021 Source ↗
• Long-term Bone Loss and Deterioration of Microarchitecture After Gastric Bypass in African American and Latina Women. · 2021 Source ↗
• Long term quality of life amongst pancreatectomy patients with diabetes mellitus. · 2021 Source ↗
• New onset diabetes predicts progression of low risk pancreatic mucinous cysts. · 2020 Source ↗
• Long-term health after pancreatic surgery: the view from 9.5 years. · 2021 Source ↗
• Interacting hepatic PAI-1/tPA gene regulatory pathways influence impaired fibrinolysis severity in obesity. · 2020 Source ↗
• Tissue-Resident Memory T Cells Mediate Immune Homeostasis in the Human Pancreas through the PD-1/PD-L1 Pathway. · 2019 Source ↗
• Noninvasive Young's modulus visualization of fibrosis progression and delineation of pancreatic ductal adenocarcinoma (PDAC) tumors using Harmonic Motion Elastography (HME) <i>in vivo</i>. · 2020 Source ↗
• Harmonic Motion Imaging of Pancreatic Tumor Stiffness Indicates Disease State and Treatment Response. · 2020 Source ↗
• The Role of Endoscopic Ultrasound-Guided Ki67 in the Management of Non-Functioning Pancreatic Neuroendocrine Tumors. · 2020 Source ↗
• Optimal Timing of Total Gastrectomy to Prevent Diffuse Gastric Cancer in Individuals With Pathogenic Variants in CDH1. · 2020 Source ↗
• Locally advanced pancreas cancer: Staging and goals of therapy. · 2019 Source ↗
• Low Frequency of Lymph Node Metastases in Patients in the United States With Early-stage Gastric Cancers That Fulfill Japanese Endoscopic Resection Criteria. · 2019 Source ↗
• Dabigatran (Pradaxa) Is Safe for Extended Venous Thromboembolism Prophylaxis After Surgery for Pancreatic Cancer. · 2019 Source ↗
• Total Pancreatectomy with Autologous Islet Cell Transplantation. · 2018 Source ↗
• Resection of Locally Advanced Pancreatic Cancer without Regression of Arterial Encasement After Modern-Era Neoadjuvant Therapy. · 2018 Source ↗
• Long-Term Surveillance and Timeline of Progression of Presumed Low-Risk Intraductal Papillary Mucinous Neoplasms. · 2017 Source ↗
• Vitamin D Storage in Adipose Tissue of Obese and Normal Weight Women. · 2017 Source ↗
• Hepatocyte DACH1 Is Increased in Obesity via Nuclear Exclusion of HDAC4 and Promotes Hepatic Insulin Resistance. · 2016 Source ↗
• Single-Institution Experience with Irreversible Electroporation for T4 Pancreatic Cancer: First 50 Patients. · 2016 Source ↗
• Facilitated long chain fatty acid uptake by adipocytes remains upregulated relative to BMI for more than a year after major bariatric surgical weight loss. · 2016 Source ↗
• Quality of life in patients after total pancreatectomy is comparable with quality of life in patients who undergo a partial pancreatic resection. · 2014 Source ↗
• Reproductive health of women electing bariatric surgery. · 2010 Source ↗

Source-reported information; confirm current details directly.